Evolus, Inc. sold 105,108 shares at $9.04 each in a transaction involving MOATAZEDI DAVID. For investors, the key ownership figure is the 499,592 shares MOATAZEDI DAVID held after the sale, showing the remaining position following the transaction.
Key Highlights
- The transaction occurred on September 2, 2026.
- MOATAZEDI DAVID held 499,592 Evolus shares after the sale.
- The transaction was listed under a “See Remarks” designation for Evolus.
Evolus, Inc. (NASDAQ: EOLS) shares changed hands at $9.04 each in a 105,108-share transaction involving MOATAZEDI DAVID. The sale leaves MOATAZEDI DAVID with 499,592 Evolus shares.
Evolus Share Transaction Details
The transaction took place on September 2, 2026. MOATAZEDI DAVID was identified in the record with a “See Remarks” designation connected to Evolus. The reported transaction involved the sale of 105,108 shares at $9.04 per share.
Remaining Evolus Ownership
The record states that MOATAZEDI DAVID sold 105,108 shares and owned 499,592 shares following the transaction.
FAQs
Q: How many Evolus shares did MOATAZEDI DAVID sell?
A: MOATAZEDI DAVID sold 105,108 Evolus shares. The filing reports a transaction price of $9.04 per share. The Form 4 identifies the sale as an SEC transaction code S.
Q: How many Evolus shares did MOATAZEDI DAVID own after the sale?
A: MOATAZEDI DAVID owned 499,592 Evolus shares after the transaction. The sale occurred on September 2, 2026. The filing reports this as ownership following the transaction.
Q: What was the price of the Evolus share transaction?
A: The reported transaction price was $9.04 per Evolus share. The filing states that the sale involved 105,108 shares on September 2, 2026.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.